Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease.
Khadzhynov D, Wagner F, Formella S, Wiegert E, Moschetti V, Slowinski T, Neumayer HH, Liesenfeld KH, Lehr T, Härtter S, Friedman J, Peters H, Clemens A.
Khadzhynov D, et al. Among authors: hartter s.
Thromb Haemost. 2013 Apr;109(4):596-605. doi: 10.1160/TH12-08-0573. Epub 2013 Feb 7.
Thromb Haemost. 2013.
PMID: 23389759
Clinical Trial.